Literature DB >> 8509369

The essential role of tropomyosin in cooperative regulation of smooth muscle thin filament activity by caldesmon.

S B Marston1, C S Redwood.   

Abstract

We compared the mechanisms by which caldesmon inhibits actin and actin-tropomyosin activation of myosin subfragment 1 (S1) MgATPase activity. Caldesmon always inhibited actin activation by displacing S1.ADP.Pi from actin and inhibition required at least 0.7 caldesmon molecules bond per actin for 90% inhibition. Caldesmon inhibited actin-tropomyosin without any displacement of S1.ADP.Pi; thus it inhibits a rate-limiting step. Inhibition is highly cooperative, requiring no more than one caldesmon bound per 10 actins for 90% inhibition of activation by actin and smooth muscle tropomyosin. The degree of cooperativity is defined by the tropomyosin since inhibition by skeletal tropomyosin requires up to one caldesmon bound per 4 actins for 90% inhibition under identical conditions. Both noncooperative inhibition of actin and cooperative, tropomyosin-dependent, inhibition are manifested by a fragment of caldesmon containing only the C-terminal 99 amino acids (658C), although this fragment does not itself bind to tropomyosin. The functional properties of 658C are very similar to striated muscle troponin I, consequently we propose a similar mechanism for tropomyosin-dependent regulation by caldesmon. Caldesmon binding switches actin-tropomyosin to the "off" or "weak" state and Ca2+/calmodulin binding to caldesmon blocks this switch and thus reactivates the actin filament.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8509369

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Vertebrate tropomyosin: distribution, properties and function.

Authors:  S V Perry
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

Review 2.  Actin and the smooth muscle regulatory proteins: a structural perspective.

Authors:  J L Hodgkinson
Journal:  J Muscle Res Cell Motil       Date:  2000-02       Impact factor: 2.698

3.  Acrylodan-labeled smooth muscle tropomyosin reports differences in the effects of troponin and caldesmon in the transition from the active state to the inactive state.

Authors:  Joseph M Chalovich; Evan Lutz; Tamatha Baxley; Mechthild M Schroeter
Journal:  Biochemistry       Date:  2011-06-14       Impact factor: 3.162

4.  Cooperative inhibition of actin filaments in the absence of tropomyosin.

Authors:  Saira Ansari; Mohammed El-Mezgueldi; Steven Marston
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

5.  Utilization of troponin C as a model calcium-binding protein for mapping of the calmodulin-binding sites of caldesmon.

Authors:  A A Polyakov; N B Gusev
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

6.  Characterization of the functional properties of smooth muscle caldesmon domain 4a: evidence for an independent inhibitory actin-tropomyosin binding domain.

Authors:  M El-Mezgueldi; O Copeland; I D Fraser; S B Marston; P A Huber
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

7.  Kinetics of binding of caldesmon to actin.

Authors:  J M Chalovich; Y D Chen; R Dudek; H Luo
Journal:  J Biol Chem       Date:  1995-04-28       Impact factor: 5.157

8.  Filamin and gelsolin influence Ca(2+)-sensitivity of smooth muscle thin filaments.

Authors:  N B Gusev; K Pritchard; J L Hodgkinson; S B Marston
Journal:  J Muscle Res Cell Motil       Date:  1994-12       Impact factor: 2.698

9.  Phosphorylation of tropomyosin extends cooperative binding of myosin beyond a single regulatory unit.

Authors:  Vijay S Rao; Ellisha N Marongelli; William H Guilford
Journal:  Cell Motil Cytoskeleton       Date:  2009-01

10.  Flexation of caldesmon: effect of conformation on the properties of caldesmon.

Authors:  R H Crosbie; J M Chalovich; E Reisler
Journal:  J Muscle Res Cell Motil       Date:  1995-10       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.